Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant

Stroke

Volumn 39, Issue 10, 2008, Pages 2765-2768

  Gaudinski, Martin R ^a   Henning, Erica C ^a   Miracle, Aaron ^a   Luby, Marie ^a   Warach, Steven ^a   Latour, Lawrence L ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Final infarct volume; Fluid attenuated inversion recovery; Lesion volume evolution; Magnetic resonance imaging; Stroke

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFARCTION; INTERRATER RELIABILITY; LINEAR REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STROKE; BRAIN INFARCTION; DISEASE COURSE; IMAGE PROCESSING; PATHOLOGY; REPRODUCIBILITY; TIME;

AGED; BRAIN INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE; TIME;

EID: 54049107725     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.512269     Document Type: Article

References (17)

1. Lovblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, Connor A, Burzynski C, Edelman RR, Warach S. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42: 164-170.
2. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The desmoteplase in acute ischemic stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
3. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37: 1227-1231.
4. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 investigators. Ann Neurol. 2000;48:713-722.
5. Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M. Effect of the glycine antagonist gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The gain MRI substudy. Cere-brovasc Dis. 2006;21:106-111.
6. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.
7. Brant-Zawadzki M, Atkinson D, Detrick M, Bradley WG, Scidmore G. Fluid-attenuated inversion recovery (flair) for assessment of cerebral infarction. Initial clinical experience in 50 patients. Stroke. 1996;27: 1187-1191.
8. Luby M, Bykowski JL, Schellinger PD, Merino JG, Warach S. Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI. Stroke. 2006;37:2951-2956.
9. Ritzl A, Meisel S, Wittsack HJ, Fink GR, Siebler M, Modder U, Seitz RJ. Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): Follow-up of diffusion-weighted MRI lesions. J Magnetic Resonance Imaging. 2004;20:201-207.
10. Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol. 2001;58:613-617.
11. Pialat JB, Wiart M, Nighoghossian N, Adeleine P, Derex L, Hermier M, Froment JC, Berthezene Y. Evolution of lesion volume in acute stroke treated by intravenous t-pa. J Magnetic Resonance Imaging. 2005;22:23-28.
12. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute is-chemic stroke with diffusion and perfusion MRI. Stroke. 2000;31: 1318-1328.
13. Delgado-Mederos R, Rovira A, Alvarez-Sabin J, Ribo M, Munuera J, Rubiera M, Santamarina E, Maisterra O, Delgado P, Montaner J, Molina CA. Speed of t-PA-induced clot lysis predicts DWI lesion evolution in acute stroke. Stroke. 2007;38:955-960.
14. Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R, Rordorf G, Buonanno FS, Schaefer PW, Gonzalez RG. Time course of lesion development in patients with acute stroke: Serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke. 1998;29:2268-2276.
15. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann Neurol. 1999;46:568-578.
16. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999;22:391-397.
17. Saver JL. Time is brain-quantified. Stroke. 2006;37:263-266.